Technology companies lead the way as US indexes shake off a slow start and rise for the fourth day in a row.
NEW YORK (AP) — U.S. stocks climbed Wednesday, driven by gains for big technology companies and Amazon. The S&P 500 and Nasdaq finished at record highs for the fourth day in a row.
Oil hit a one-month high as energy stocks helped lift Canada’s main stock index slightly and investors watched for any positive signs from NAFTA negotiations.
While the bull run isn’t over yet, investors are making moves—or considering moves—in their equity positions.
“We decided it was best to take one step in becoming a bit more conservative at this point in time,” says a weekly Richardson GMP market insight report.
This stock is on track for its biggest-ever one-day gain
Shares of discount footwear and accessories retailer DSW Inc. soared more than 20% Tuesday to put them on track for their biggest-ever one-day gain, after the company crushed earnings estimates for the second quarter and raised its full-year guidance.
The stock market has been on a tear since 2009, but it won’t always go up.
CAMBRIDGE, Mass. (Project Syndicate) — The U.S. stock market achieved its longest rise in its history on Aug. 22, with the Standard and Poor’s 500 index SPX, +0.03% up by 230% since 2009. Although this wasn’t the biggest increase in a bull market, it marked the longest period of increasing share prices.
In a world increasingly interconnected, billions of people rely on the web to chat, socialize and share. That has turned social-media platforms into powerful tools for communication, entertainment, social justice and change.
European markets inched higher on Wednesday, tracking recent gains in U.S. markets that came on an apparent easing of trade-related tensions.
Weekly Market Review – January 4, 2025
Orion to use Aitia’s ‘digital twins’ to identity potential new cancer drugs
Windtree’s cardiogenic shock med raises blood pressure in latest phase 2 win
Merck’s Keytruda-LAG-3 combo fails to tame tough colorectal cancer in phase 3
New PicnicHealth service brings observational clinical trial research to the virtual world
OncoC4 founders take own science under their wing in new biotech merger
BioAge Labs aims to raise $180M from IPO, private placement to fund obesity trials
Amgen reports first phase 3 win for $400M eczema drug, but Dupixent rivalry doubts remain
Clinical trial site network Headlands Research opens new location in El Paso, Texas
NewHold Investment Corp. III Files to Offer Up to 20M Units in IPO
